Skip to content

Preparing for the Bursting of the Psychedelic Hype Bubble.

David B. Yaden, James B. Potash, Roland R. Griffiths

JAMA Psychiatry October 1, 2022 DOI: 10.1001/jamapsychiatry.2022.2546 via PubMed

Summary

AI-generated from the abstract

Public perception of psychedelics has swung from extreme stigma to uncritical enthusiasm, creating obstacles for clinical application. This viewpoint argues that both poles are problematic and advocates for continued scientific study while encouraging critical examination of claims not supported by evidence. The authors call for a balanced approach that neither dismisses therapeutic potential nor overpromises benefits, emphasizing the need for rigorous research to guide responsible clinical integration.

Study at a glance

Characteristics Viewpoint Peer reviewed
Topics Psychedelic-assisted therapy
Keywords Psychedelic medicine Entheogenic treatment Hallucinogen-assisted therapy Mental health psychedelics
Citations 153
Key finding Extreme shifts in public perception of psychedelics create impediments to clinical application, and claims not supported by evidence should be disputed.

Abstract

This Viewpoint presents impediments to the clinical application of psychedelics created by extreme shifts in public perception while advocating further study and encouraging the dispute of claims not supported by available evidence.

Explore topics

Comments

No comments yet.

Log in to comment